van der Horst-Bruinsma IE - Search Results

1

Study on the protective effect of the KIR3DL1 gene in ankylosing spondylitis.

Vendelbosch S, Heslinga SC, John M, van Leeuwen K, Geissler J, de Boer M, Tanck MW, van den Berg TK, Crusius JB, van der Horst-Bruinsma IE, Kuijpers TW. Vendelbosch S, et al. Arthritis Rheumatol. 2015 Nov;67(11):2957-65. doi: 10.1002/art.39288. Arthritis Rheumatol. 2015. PMID: 26238044

2

Increased risk of developing ankylosing spondylitis among first-born children.

Baudoin P, van der Horst-Bruinsma IE, Dekker-Saeys AJ, Weinreich S, Bezemer PD, Dijkmans BA. Baudoin P, et al. Arthritis Rheum. 2000 Dec;43(12):2818-22. doi: 10.1002/1529-0131(200012)43:12<2818::AID-ANR23>3.0.CO;2-F. Arthritis Rheum. 2000. PMID: 11145041 Free article.

3

Is disease severity in ankylosing spondylitis genetically determined?

Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, Brown MA. Hamersma J, et al. Arthritis Rheum. 2001 Jun;44(6):1396-400. doi: 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A. Arthritis Rheum. 2001. PMID: 11407700 Free article.

4

Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.

van der Horst-Bruinsma IE, Clegg DO, Dijkmans BA. van der Horst-Bruinsma IE, et al. Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S67-70. Clin Exp Rheumatol. 2002. PMID: 12463451 Review.

5

Dutch patients with familial and sporadic ankylosing spondylitis do not differ in disease phenotype.

Paardt Mv, Dijkmans B, Giltay E, van der Horst-Bruinsma I. Paardt Mv, et al. J Rheumatol. 2002 Dec;29(12):2583-4. J Rheumatol. 2002. PMID: 12465156

6

Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis.

van der Paardt M, Crusius JB, García-González MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE. van der Paardt M, et al. Rheumatology (Oxford). 2002 Dec;41(12):1419-23. doi: 10.1093/rheumatology/41.12.1419. Rheumatology (Oxford). 2002. PMID: 12468823

7

CARD15 gene mutations are not associated with ankylosing spondylitis.

van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE. van der Paardt M, et al. Genes Immun. 2003 Jan;4(1):77-8. doi: 10.1038/sj.gene.6363914. Genes Immun. 2003. PMID: 12595906

8

Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.

van Denderen JC, van der Horst-Bruinsma I, Bezemer PD, Dijkmans BA. van Denderen JC, et al. J Rheumatol. 2003 Jul;30(7):1558-60. J Rheumatol. 2003. PMID: 12858458 Clinical Trial.

9

Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Peters MJ, et al. Semin Arthritis Rheum. 2004 Dec;34(3):585-92. doi: 10.1016/j.semarthrit.2004.07.010. Semin Arthritis Rheum. 2004. PMID: 15609262 Review.

10

No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.

van der Paardt M, Crusius JB, de Koning MH, Morré SA, van de Stadt RJ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE. van der Paardt M, et al. Ann Rheum Dis. 2005 Feb;64(2):235-8. doi: 10.1136/ard.2004.021105. Ann Rheum Dis. 2005. PMID: 15647432 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters